EMEA grants orphan drug designation to Tengion for Neo-Bladder Augment for spina bifida April 7, 2008
ProtAffin is awarded EUR 1.1 million research grant in Austria for development of PA-401 April 4, 2008
AEterna Zentaris initiates second phase III trial of cetrorelix for benign prostatic hyperplasia March 28, 2008